Navigation Links
Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show
Date:11/9/2009

NBC’s Today Show featured a return of the Berns Triplets and their physician, Dr. Jill Waibel on Friday Nov. 6th 2009, The segment followed up with Chandra, Jordan and Trae Berns after their first appearance on the Today Show on May 28th 2009 in which they were interviewed by Matt Lauer regarding their treatments by Dr. Jill Waibel of Miami, FL with Lumenis’ UltraPulse TotalFX laser.

(PRWEB) November 9, 2009 -- NBC’s Today Show featured a return of the Berns Triplets and their physician, Dr. Jill Waibel on Friday Nov. 6th 2009, The segment followed up with Chandra, Jordan and Trae Berns after their first appearance on the Today Show on May 28th 2009 in which they were interviewed by Matt Lauer regarding their treatments by Dr. Jill Waibel of Miami, FL with Lumenis’ UltraPulse TotalFX laser.    

The return segment, which aired Friday, November 6th, clearly showed viewers the dramatic improvement in the burn scars of all three sisters – scars which were inflicted upon them in an arson fire as infants. After twenty years of seeking treatment, they have found hope with Dr. Jill Waibel and Lumenis’ UltraPulse TotalFX system. Their remarkable results have inspired many other people with burn scars around the world to seek out Dr. Waibel and the TotalFX treatment to help them with their own scars.

“Chandra, Jordan and Trae have all shown considerable improvement in their scars after treatments using Lumenis’ TotalFX”, commented Dr. Waibel. “Because of their amazing progress, word has spread and I’ve treated over a hundred other burn patients in my practice alone. We are quickly advancing our knowledge on the science behind burn scars and the best solution for treatment”. Dr. Waibel is now a frequent guest lecturer on burn scar treatments at many physician societies and has quickly established herself as the physician’s resource for scar revision.

“It’s important that we continue to learn and explore the best possible solutions for these types of treatments” cautioned Dr. Waibel. “Not all lasers are alike, and although other lasers may be indicated for scar revision, my treatment of choice is the TotalFX.” The TotalFX treatment is powered by Lumenis’ UltraPulse CO2 laser and the UltraPulse is the only laser available that delivers energy in the patented UltraPulse mode.

Lumenis pioneered skin resurfacing over 18 years ago with its C02 lasers. The Lumenis UltraPulse laser system has FDA clearance for more than 34 indications and is referenced in excess of 90 peer-reviewed publications. Although frequently used for aesthetic applications, the UltraPulse offers 240 watts of power and microsecond pulses which combined provide a broad canvas from which other treatments in cutaneous surgical and aesthetic applications can be provided. No other laser available today offers UltraPulse delivery and remains the standard for treating scars among all CO2 lasers.

The entire story of the Berns triplets and their treatments using the UltraPulse Fractional CO2 laser can be found at www.bernstriplets.com. For more information on the UltraPulse laser go to www.aesthetic.lumenis.com

About Lumenis
Lumenis is Israel’s largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, presence in over 100 countries worldwide, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com.

Lumenis® is a registered trademark of Lumenis Ltd.
UltraPulse® is a trademark of Lumenis Ltd.

For further information contact:
Michelle Maydan
Director of Corporate Communications
1-866-569-0597
+972-4-959-9004

Certain statements and information in this press release may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements may be found in our most recent Annual Report on Form 20-F, including the section therein entitled “Risk Factors”, as well in our reports on Form 6-K, filed with the Securities and Exchange Commission.

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3175754.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME)
2. Lumenis Continued Dedication to Life-Saving Procedures Helps a Small Girl in Iceland Get a New Lease on Life
3. Lumenis, Worlds Largest Medical Laser Company, Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
4. Lumenis UltraPulse TotalFX Treatment Featured on ABCNews 20/20 as a Secret Weapon for Treating for Burn Scars
5. Lumenis High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating Pain and Nuisance of Hair Removal for Men
6. Lumenis Completes $15 Million Equity Financing From New and Existing Investors
7. Lumenis High Speed LightSheer(R) Duet(TM) Featured on ABCs Good Morning America Health as the New Gold Standard for Laser Hair Removal
8. Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology
9. Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the Today Show
10. Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
11. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Development Team of Pixel Film Studios Announced ... "This new layered style transition tool will keep a consistent flow to your project ... Film Studios. , TranSweep is an all new layered style transition tool for ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dalton Pharma Services, ... has successfully completed another Health Canada inspection and has received a compliant rating ... resulted from a Good Manufacturing Practices (GMP) inspection conducted at Dalton’s facility during ...
(Date:5/26/2016)... ... 26, 2016 , ... Women’s athletic apparel company GRACEDBYGRIT is ... shop for three consecutive weekends. The pop-up shop is a great way to ... community full of women who appreciate the most premium goods and vibrant events. ...
(Date:5/26/2016)... ... 26, 2016 , ... Bunion Bootie is a great option for ... save. For a limited time only (offer expires May 31, 2016) customers can save ... by using the promo code "Memorial" at checkout. The more Bunion Booties purchased, the ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... Association/American Stroke Association's Get With The Guidelines®-Stroke Gold Plus Achievement Award with ... second for Memorial Healthcare System, recognizes its commitment to emergency stroke care ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 2016 Since its commercial introduction ... essential life science tool for conducting genetic studies in ... reveals in its new report that the industry sits ... powered by a range of new applications in the ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
Breaking Medicine Technology: